Literature DB >> 17962936

Genetic association studies in osteonecrosis of the femoral head: mini review of the literature.

Georgios Hadjigeorgiou1, Efthimios Dardiotis, Maria Dardioti, Apostolos Karantanas, Apostolos Dimitroulias, Konstantinos Malizos.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 17962936     DOI： 10.1007/s00256-007-0395-2

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN： 0364-2348            Impact factor:   2.199


× No keyword cloud information.
  44 in total

1.  The 677C-->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head.

Authors:  Charalampos G Zalavras; Konstantinos N Malizos; Eleni Dokou; George Vartholomatos
Journal:  Haematologica       Date:  2002-01       Impact factor: 9.941

2.  The beta fibrinogen gene G-455-A polymorphism is a risk factor for Legg-Perthes disease.

Authors:  A Dilley; W C Hooper; H Austin; M Jamil; C Miller; M Stokes; B Evatt; J Eldridge
Journal:  J Thromb Haemost       Date:  2003-11       Impact factor: 5.824

3.  Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis.

Authors:  Clinton Baldwin; Vikki G Nolan; Diego F Wyszynski; Qian-Li Ma; Paola Sebastiani; Stephen H Embury; Alice Bisbee; John Farrell; Lindsay Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

4.  Resistance to activated protein C and Legg-Perthes disease.

Authors:  C J Glueck; G Brandt; R Gruppo; A Crawford; D Roy; T Tracy; D Stroop; P Wang; A Becker
Journal:  Clin Orthop Relat Res       Date:  1997-05       Impact factor: 4.176

5.  [Incidence of thrombophilic factor V Leiden and prothrombin G20210A mutation in Perthes disease--a pilot study].

Authors:  A Schmitz; J Pförtner; A Protzel; U Harbrecht
Journal:  Z Orthop Ihre Grenzgeb       Date:  2001 Mar-Apr

6.  Prospective reevaluation of the association between thrombotic diathesis and legg-perthes disease.

Authors:  M Timothy Hresko; Patricia A McDougall; Jed B Gorlin; Eleftherios C Vamvakas; James R Kasser; Ellis J Neufeld
Journal:  J Bone Joint Surg Am       Date:  2002-09       Impact factor: 5.284

7.  Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease.

Authors:  S A Zimmerman; R E Ware
Journal:  Am J Hematol       Date:  1998-12       Impact factor: 10.047

8.  Increased frequency of white matter lesions in patients with osteonecrosis (WMLeOn) of the femoral head.

Authors:  Georgios M Hadjigeorgiou; Apostolos H Karantanas; Aristidis Zibis; Efthimios Dardiotis; Konstantinos Aggelakis; Alexandros Papadimitriou; Konstantinos Malizos
Journal:  Eur J Radiol       Date:  2004-06       Impact factor: 3.528

Review 9.  Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals.

Authors:  J H Boss; I Misselevich
Journal:  Vet Pathol       Date:  2003-07       Impact factor: 2.221

10.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321
View more
  25 in total

1.  Combined effect of tnf-α polymorphisms and hypoxia on steroid-induced osteonecrosis of femoral head.

Authors:  Yaosheng Liu; Weihao Jiang; Shubin Liu; Xiuyun Su; Shiguo Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.

Authors:  Smita Bhatia
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10       Impact factor: 4.254

3.  Pathophysiology and risk factors for osteonecrosis.

Authors:  Kalpit N Shah; Jennifer Racine; Lynne C Jones; Roy K Aaron
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

4.  Osteonecrosis of the femoral head: genetic basis.

Authors:  Tracy Wang; Bouziane Azeddine; Wayne Mah; Edward J Harvey; David Rosenblatt; Chantal Séguin
Journal:  Int Orthop       Date:  2018-10-17       Impact factor: 3.075

5.  Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Jitesh D Kawedia; Sue C Kaste; Deqing Pei; John C Panetta; Xiangjun Cai; Cheng Cheng; Geoffrey Neale; Scott C Howard; William E Evans; Ching-Hon Pui; Mary V Relling
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

6.  Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province.

Authors:  Yizhou Li; Yongchang Guo; Quanjian Wang; Yongri Ouyang; Yuju Cao; Tianbo Jin; Jianzhong Wang
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

7.  Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway.

Authors:  Qingtang Miao; Sibin Hao; Hongmei Li; Fang Sun; Xueling Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  Effects of osteoprotegerin, RANK and RANKL on bone destruction and collapse in avascular necrosis femoral head.

Authors:  Ming-Yue Xiong; Li-Qiang Liu; Shi-Qiong Liu; Zhen-Hui Liu; Hang-Fei Gao
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

9.  Bone morphogenetic proteins (BMPs) expression in the femoral heads of patients with avascular necrosis.

Authors:  Stavroula Samara; Zoe Dailiana; Sokratis Varitimidis; Christos Chassanidis; Theodora Koromila; Konstantinos N Malizos; Panagoula Kollia
Journal:  Mol Biol Rep       Date:  2013-05-07       Impact factor: 2.316

10.  High Serum Alpha-2-Macroglobulin Level in Patients with Osteonecrosis of the Femoral Head.

Authors:  Zari Naderi Ghale-Noie; Mohammad Hassani; Amir R Kachooei; Mohammad A Kerachian
Journal:  Arch Bone Jt Surg       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.